These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25239131)

  • 1. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.
    Kataoka TR; Kumanogoh A; Fukuishi N; Ueshima C; Hirata M; Moriyoshi K; Tsuruyama T; Haga H
    Int Immunol; 2015 Feb; 27(2):95-103. PubMed ID: 25239131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD72 negatively regulates KIT-mediated responses in human mast cells.
    Kataoka TR; Kumanogoh A; Bandara G; Metcalfe DD; Gilfillan AM
    J Immunol; 2010 Mar; 184(5):2468-75. PubMed ID: 20100931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.
    Kataoka TR; Kumanogoh A; Hirata M; Moriyoshi K; Ueshima C; Kawahara M; Tsuruyama T; Haga H
    Sci Rep; 2013 Oct; 3():2861. PubMed ID: 24713856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.
    Ishida I; Kumanogoh A; Suzuki K; Akahani S; Noda K; Kikutani H
    Int Immunol; 2003 Aug; 15(8):1027-34. PubMed ID: 12882840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.
    Yamazaki S; Nakano N; Honjo A; Hara M; Maeda K; Nishiyama C; Kitaura J; Ohtsuka Y; Okumura K; Ogawa H; Shimizu T
    J Immunol; 2015 Oct; 195(7):3427-35. PubMed ID: 26297757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
    Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
    J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72.
    Mizrahi S; Markel G; Porgador A; Bushkin Y; Mandelboim O
    PLoS One; 2007 Sep; 2(9):e818. PubMed ID: 17786190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
    Kumanogoh A; Watanabe C; Lee I; Wang X; Shi W; Araki H; Hirata H; Iwahori K; Uchida J; Yasui T; Matsumoto M; Yoshida K; Yakura H; Pan C; Parnes JR; Kikutani H
    Immunity; 2000 Nov; 13(5):621-31. PubMed ID: 11114375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative roles of CD72 in B cell function.
    Wu HJ; Bondada S
    Immunol Res; 2002; 25(2):155-66. PubMed ID: 11999169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.
    Qu X; Miah SM; Hatani T; Okazaki M; Hori-Tamura N; Yamamura H; Hotta H; Sada K
    J Biochem; 2005 Jun; 137(6):711-20. PubMed ID: 16002993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6.
    Shimizu Y; Suga T; Maeno T; Aoki F; Tsukagoshi H; Kawata T; Sakai K; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
    Clin Exp Allergy; 2004 Jun; 34(6):917-25. PubMed ID: 15196280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
    Kumanogoh A; Shikina T; Watanabe C; Takegahara N; Suzuki K; Yamamoto M; Takamatsu H; Prasad DV; Mizui M; Toyofuku T; Tamura M; Watanabe D; Parnes JR; Kikutani H
    Int Immunol; 2005 Oct; 17(10):1277-82. PubMed ID: 16113236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.
    Wu HJ; Bondada S
    J Clin Immunol; 2009 Jan; 29(1):12-21. PubMed ID: 19067131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
    Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
    J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel high-affinity IgE receptor-positive canine mast cell line with wild-type c-kit receptors.
    Amagai Y; Tanaka A; Ohmori K; Matsuda H
    Biochem Biophys Res Commun; 2008 Feb; 366(3):857-61. PubMed ID: 18086553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagalloylglucose down-regulates mast cell surface FcepsilonRI expression in vitro and in vivo.
    Kageyama-Yahara N; Suehiro Y; Maeda F; Kageyama S; Fukuoka J; Katagiri T; Yamamoto T; Kadowaki M
    FEBS Lett; 2010 Jan; 584(1):111-8. PubMed ID: 19903473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis.
    Nakano S; Morimoto S; Suzuki J; Mitsuo A; Nakiri Y; Katagiri A; Nozawa K; Amano H; Tokano Y; Hashimoto H; Takasaki Y
    Autoimmunity; 2007 Feb; 40(1):9-15. PubMed ID: 17364492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking.
    Fusaki N; Tomita S; Wu Y; Okamoto N; Goitsuka R; Kitamura D; Hozumi N
    Eur J Immunol; 2000 May; 30(5):1326-30. PubMed ID: 10820378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual regulation of BCR-mediated growth inhibition signaling by CD72.
    Baba T; Fusaki N; Aoyama A; Li DH; Okamura RM; Parnes JR; Hozumi N
    Eur J Immunol; 2005 May; 35(5):1634-42. PubMed ID: 15816000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.
    Mirzahosseini A; Dalmadi B; Csutora P
    Cell Immunol; 2013; 283(1-2):38-44. PubMed ID: 23850674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.